Oxidative stress plays a major pathogenetic role in cardiovascular disease. The C242T variant of the CYBA gene encoding the p22phox subunit of the NAD(P)H oxidase, a major source of superoxide production, has been shown to be associated with coronary artery disease and with vascular superoxide production in human veins ex vivo. Since superoxide degrades nitric oxide (NO), we hypothesized that the C242T variant influences endothelium-dependent vasodilation of the human forearm vasculature in vivo. In the present study, 90 subjects with elevated cholesterol levels were stratifed for the C242T polymorphism of the CYBA p22phox gene. Endothelium-dependent and -independent vasodilation were assessed by plethysmographic monitoring of forearm blood flow responses to intra-arterial infusion of acetylcholine and sodium nitroprusside respectively. N G -Monomethyl-L-arginine (L-NMMA) was infused to analyse NO-mediated basal vascular tone. Baseline parameters (age, gender, blood pressure, body mass index, cholesterol level) were similar across the genotypes. No differences in forearm blood flow responses to the intraarterial infusion of acetylcholine, sodium nitroprusside or L-NMMA were found across the CYBA p22phox genotypes. Our sample size of n = 90 had a power of > 80 % (β = 0.20) with a P value of < 0.05 (α = 0.05) to detect a difference greater than 156 % in the forearm blood flow response to acetylcholine across genotypes (S.D. 336 %; average increase in forearm blood flow = 514 %).
INTRODUCTION
Oxidative stress plays a major pathogenetic role in atherosclerosis and cardiovascular disease. Reactive oxygen species lead to the degradation of endothelium-derived nitric oxide (NO), and thus constitute an important cause of impaired endothelium-dependent vasodilation in various cardiovascular disorders. Antioxidant agents have been proven to be useful in restoring closely associated with the presence of cardiovascular risk factors and impaired endothelium-dependent vasodilation in human arteries [8] . In that study [8] , diabetes mellitus and hypercholesterolaemia were independently associated with increased NAD(P)H-dependent superoxide production. Moreover, inhibition of NADP(H) oxidase was recently shown to ameliorate endothelial dysfunction of internal mammary arteries in patients undergoing coronary artery bypass grafting [9] .
A putatively functional polymorphism of the CYBA gene encoding the p22phox subunit of NAD(P)H oxidase has been described [10] . The C242T variant results in the substitution of tyrosine for histidine within one of the two haem-binding sites that are thought to be essential for the stability of the protein. In a Japanese case-control study, the 242T variant of the CYBA gene was found to be associated with a lower risk of coronary artery disease [10] . In contrast, a study from Australia found an increased risk of coronary artery disease in carriers of the T allele [11] , and another study from Japan reported an increased risk of stroke in association with the T allele [12] . Furthermore, an American group of investigators were able to show that the T allele is associated with more rapid progression of angiographically visualized coronary artery disease over a study period of 2.5 years [13] . However, there have also been results negating a link between C242T p22phox genotype and coronary artery disease. Two large studies, one American [14] and one German study with over 2000 subjects [15] , reported no association between C242T p22phox genotype and coronary artery disease.
Thus, proof of the functional relevance of this gene polymorphism in vivo is needed. In a first study examining the functional consequences of the p22phox polymorphism, the 242T variant was linked with reduced basal and stimulated vascular superoxide production in human veins ex vixo [16] . However, functional data in vivo in humans are still lacking. Direct assessment of oxidative stress in the vasculature is still difficult. Since it is well known that superoxide degrades NO, we hypothesized that the C242T polymorphism of the CYBA p22phox gene may influence endothelium-dependent vasodilation or basal NO-mediated vascular tone in the arterial forearm circulation in humans. Subjects with elevated cholesterol levels were examined, since increased oxidative stress in the vasculature has been shown to be mediated by the NADP(H) oxidase pathway in this condition [8, 17, 18] .
METHODS

Study population
Following advertisement in the local newspaper, 90 subjects were consecutively enrolled that fulfilled all inclusion criteria. The study population consisted of male and female Caucasians living in the Nuremberg region of Bavaria, Germany. Informed written consent was obtained from each individual, and the study protocol was approved by the University Investigation Ethics Committee. The study was carried out in accordance with the Declaration of Helsinki.
Volunteers were eligible for the study if they were between 18 and 70 years of age. Subjects with elevated serum cholesterol levels [total cholesterol > 200 mg/dl or low-density lipoprotein (LDL) cholesterol > 160 mg/dl] were included in the study. Exclusion criteria were as follows: overt cardiovascular disease (i.e. a history of angina pectoris); myocardial infarction; percutaneous transluminal coronary angioplasty; coronary artery bypass graft; congestive heart failure; history or clinical signs of carotid artery disease, renovascular disease, peripheral artery disease or any other cardiovascular disease; familial monogenic hypercholesterolaemia; secondary hyperlipoproteinaemia; vascular abnormalities in the forearm vasculature; Type I or Type II diabetes mellitus; smoking; liver disease (aspartate aminotransferase and alanine aminotransferase levels > 120 % of upper normal limit); kidney disease (alkaline phosphatase, bilirubin and serum creatinine > 150 % of upper normal limit); any current medication or any history of cardiovascular medication, including antihypertensive therapy and antihyperlipidaemic treatment, in particular the use of statins.
Assessment of forearm blood flow
Forearm blood flow and responses to various vasoactive drugs were assessed by forearm plethysmography, as described previously [19] . In brief, an intra-arterial line was inserted into the brachial artery of the left arm. After 30 min of rest, forearm vascular responsiveness to vasoactive agents was assessed by venous occlusion plethysmography (EC 5R plethysmograph; Hokansson). Drugs were given by intra-arterial infusion at a rate of 2 ml/min. The following substances were administered (each dose was infused for 5 min): (1) acetylcholine, to assess endothelium-dependent vasodilation, at sequential doses of 12 and 48 µg/min; (2) sodium nitroprusside, to test endothelium-independent vascular relaxation, at doses of 3.2 and 12.8 µg/min; and (3) N G -monomethyl-larginine (l-NMMA), to test basal production and release of NO, at doses of 4, 8 and 16 µmol/min. Before each intervention, saline was infused for 15 min to allow forearm blood flow to return to resting levels. Baseline forearm blood flow was obtained from an average of three measurements. No significant changes in blood pressure or heart rate were observed during drug administration, which confirmed the local administration of each drug.
Genotyping
Genomic DNA was extracted from 2-5 ml of whole blood by standard methods using a commercially available kit (QIAamp Blood Midi Kit; QIAGEN G.m.b.H., Hilden, Germany). Genotyping for the C242T p22phox polymorphism was performed as described by Cahilly et al. [13] by a combined PCR-restrictiondigestion approach. To avoid mistyping, the PCR fragment contained the diagnostic recognition site for the restriction enzyme RsaI (New England Biolabs, Beverly, MA, U.S.A.) and a second recognition site for the same enzyme to confirm complete digestion after agarose gel electrophoresis of the reaction products [13] .
Statistical analysis
All statistical analyses were carried out using SPSS software [20] . Paired Student's t tests were used to test the significance of changes during infusion of the vasoactive agents compared with baseline. χ 2 -tests were used to test for deviation of genotype distributions from the HardyWeinberg equilibrium and for gender distribution. ANOVA for repeated measurements with the Bonferroni correction was performed to compare groups stratified according to tertiles of various cardiovascular risk factors or according to the examined genotypes.
Changes in forearm blood flow are expressed in absolute terms and as the percentage change from the corresponding baseline. All data in the text are given as means + − S.D. Two-tailed values of P < 0.05 were considered statistically significant.
RESULTS
Study population
The clinical characteristics of the total study population are given in Table 1 , and clinical characteristics for men and women seperately are given in Table 2 . A total of 90 subjects (41 female/49 male) were included in the study protocol.
Intra-arterial infusion of acetylcholine caused a significant, dose-dependent increase in forearm blood flow (P < 0.01). The observed change in forearm blood flow in response to acetylcholine was correlated inversely with both body mass index (r = − 0.24, P = 0.02 at a dose of 48 µg/min acetylcholine) and LDL cholesterol levels (r = − 0.21, P = 0.05), and positively with highdensity lipoprotein (HDL) cholesterol levels (r = 0.47, P = 0.01). When subjects were classified into tertiles according to LDL cholesterol levels, subjects in the top 11.5 + − 3.6 9.6 + − 2.0 tertile had a significantly impaired forearm blood flow response compared with subjects in the lower tertiles (P = 0.002) (Figure 1 ). The infusion of l-NMMA caused significant, dose-dependent decreases in forearm blood flow (P < 0.01).
Allele frequencies and baseline parameters in subjects stratified according to genotype
All subjects could be genotyped unambigously for the C242T polymorphism of the CYBA p22phox gene. The frequencies of the C and T alleles were 61.7 % and 38.3 % respectively. Genotype frequencies did not deviate from the Hardy-Weinberg equilibrium and were similar to those in a previous report from Germany [15] . No differences in clinical parameters were detected across the genotypes (Table 3 ). 
Relationship between genotype and endothelium-dependent vasodilation
Baseline values of forearm blood flow at rest were similar between the C242T genotypes (Table 3) . Intraarterial infusion of acetylcholine caused significant, dose-dependent increases in forearm blood flow in all genotypes (P < 0.01). The average increase was 514 % at an acetylcholine dose of 48 µg/min. The C242T genotype did not affect the increase in forearm blood flow in response to acetylcholine, irrespective of whether this is given in absolute terms or as percentage change from baseline (Table 4 , Figure 2 ). Power analysis disclosed that, based on the actual S.D. of 336 %, a difference of 156 % in the percentage change in forearm blood flow in response to the higher dose of acetylcholine can be excluded with a power of 0.80, and a difference of 235 % can be excluded with a power of 0.99.
Table 3 Clinical characteristics of the subjects stratified according to C242T genotype
No significant differences according to the C242T genotype were found by ANOVA. In addition, when examining the effect of the C242T genotype in subgroups of men and women separately, or in subjects older or younger than the median of 49 years separately, still no effect of the C242T genotype on endothelium-dependent vasodilation could be disclosed.
Relationship between genotype and endothelium-dependent vasoconstriction
Baseline values of forearm blood flow before infusion of the vasoconstrictor agent l-NMMA were not different between genotypes (Table 3 ). The infusion of l-NMMA caused significant, dose-dependent decreases in forearm blood flow in all genotypes (P < 0.01), with an average decrease of 33 % at an l-NMMA dose of 16 µmol/min. There were no significant differences between genotypes (Table 4, Figure 3 ). Based on the actual S.D. of 15.7 %, for the highest dose of l-NMMA, a difference of 7.4 % can be excluded with a power of 0.80 and a difference Change in forearm blood flow (ml · min −1 · 100 ml Values are means + − S.E.M. N.S., not significant. of 11.0 % can be excluded with a power of 0.99 for the CYBA C242T p22phox genotype. Similarly, when examining the effect of the C242T genotype in subgroups of men and women, or subjects older or younger than 49 years, no effect of the C242T genotype on endothelium-dependent vasoconstriction could be detected.
DISCUSSION
We hypothesized that the observed associations between the C242T polymorphism of the CYBA p22phox gene and cardiovascular disease could be further clarified on the basis of altered endothelium-dependent vasodilation or basal NO-mediated vascular tone. However, our data in subjects with elevated cholesterol levels do not support a major effect of the C242T polymorphism on the parameters of endothelial function studied.
With regard to the quantity of reactive oxygen species produced, the NAD(P)H oxidase system was found to be the most important system compared with other superoxide anion-producing enzymes, such as xanthine oxidase, the lipoxygenases or uncoupled endothelial NO synthase [5] [6] [7] . NAD(P)H oxidase in endothelium and vascular smooth muscle cells is structurally similar to that found in neutrophil granulocytes, but important functional differences exist. The vascular NAD(P)H oxidases are low-output, slow-release enzymes with an estimated O − 2 production of about one-third the capacity of that in the neutrophil granulocyte [21] . However, the vascular enzymes seem to have a constitutive activity that is regulated by numerous vasoactive substances, such as angiotensin II, and by haemodynamic forces [22] . An association between cardiovascular risk factors, increased NAD(P)H oxidase activity and impaired NO-mediated endothelium-dependent vasodilation was recently demonstrated in human venous saphenous veins ex vivo [8] . The role of NAD(P)H oxidase as an important contributor to impaired endotheliumdependent vasodilation has been documented, particularly for subjects with hypercholesterolaemia [8, 17, 18] . Therefore we chose to examine the role of the C242T polymorphism of the p22phox CYBA gene in subjects with elevated cholesterol levels.
Recently, an association of the CYBA 242T allele with reduced NAD(P)H oxidase activity in human saphenous veins was demonstrated in an ex vivo experimental setting, thereby suggesting a functional effect of the C242T polymorphism on superoxide production [16] . Since superoxide production leads to increased degradation of NO, we hypothesized that the C242T polymorphism may influence endothelium-dependent vasodilation in the human forearm circulation. However, no differences were found across the genotypes. Similarly, Li et al. [14] also failed to demonstrate an influence of this gene polymorphism on endothelium-dependent vasodilation in the coronary circulation in subjects with established coronary artery disease. Unlike Li et al. [14] , we were also able to examine the forearm blood flow response to l-NMMA as a marker of NO-mediated basal vascular tone, which it is not feasible to study in the coronary circulation. Again, no relevant effect of the C242T polymorphism on NO-mediated basal vascular tone could be demonstrated. In addition to these results, a recent study failed to show a difference in malondialdehyde levels as a measure of lipid peroxidation across the genotypes of the C242T p22phox polymorphism in patients with coronary artery disease [23] .
Since negative results of association studies are more difficult to interpret than positive results, the limitations of our study have to be discussed. One limitation might derive from our particular infusion protocol, with acetylcholine used as a stimulator of endotheliumdependent vasodilation. One reason why we used acetylcholine was the fact that acetylcholine-induced vasodilation has been shown repeatedly to be a powerful and independent predictor of future cardiovascular events [24] [25] [26] . However, acetylcholine-induced vasodilation is mediated not only by NO, but also by prostaglandins and endothelium-derived hyperpolarization factor (EDHF), and differs in various disease states and various vascular beds. In subjects with hypercholesterolaemia, EDHF may be responsible for acetylcholine-induced vascular responses to a significant extent. In future experiments, stimulators of endothelium-dependent vasodilation that are more exclusively dependent on NO, such as 5-hydroxytryptamine (serotonin) [27] , may yield different results. In addition, to quantify the influence of NADP(H) oxidase on vascular responses, the use of an NADP(H) oxidase inhibitor would be interesting. Although a specific inhibitor of NADP(H) oxidase exists [28] , it has not been used in humans so far. Furthermore, due to the low frequency of the T allele, only 11 subjects with the TT genotype were included in our study. Although genotype frequencies in the present study were similar to those in a previous large study in a German population [15] , this may limit the statistical power to detect functional differences between genotypes.
Aside from these methodological issues, several biological considerations may explain the negative result. Due to the numerous biological effects of reactive oxygen species, any associations between the p22phox C242T polymorphism and cardiovascular disease might be mediated by alterations in other atherosclerosispromoting processes that cannot be disclosed by measuring endothelium-dependent vasodilation. To name only a few, reactive oxygen species have been shown to promote plaque formation by the induction of vascular smooth muscle growth, oxidation of LDL cholesterol and enhanced expression of inflammatory molecules such as MCP-1 (monocyte chemotactic protein-1) and VCAM-1 (vascular cell adhesion molecule-1) [29] . In addition to the vascular NAD(P)H oxidase system, generation of reactive oxygen species in the neutrophil granulocytes, which can be found in the shoulder regions of coronary plaques [30] , might be modulated by the C242T polymorphism and thus influence plaque rupture. Moreover, the association of a gene polymorphism with a disease may be due to an effect of an as yet unidentified gene locus that is in linkage disequilibrium with the known polymorphism [31] . Thus an as yet unknown gene variant might be responsible for the observed association between the CYBA p22phox C242T gene polymorphism and coronary artery disease.
In conclusion, in subjects with elevated cholesterol levels, our data do not support a major effect of the p22phox C242T polymorphism on acetylcholineinduced endothelium-dependent vasodilation or on basal NO-mediated vascular tone.
